CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, cilt.6, sa.8, ss.1926-1933, 2011 (SCI-Expanded)
Background and objectives Left ventricular hypertrophy (LVH) is an independent risk factor and an intermediate end point of dialysis-associated cardiovascular comorbidity. We utilized a global pediatric registry to assess the prevalence, incidence, and predictors of LVH as well as its evolution in the longitudinal follow-up in dialyzed children.